Brivaracetam
| Brivaracetam | |
|---|---|
| IUPAC name | (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide |
| Properties | |
| Molecular formula | C11H20N2O2 |
| Molar mass | 212.29 g mol-1 |
| Pharmacology | |
| Routes of administration |
Oral |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
Brivaracetam is a racetam derivative with anticonvulsant properties.
See also
Racetams |
|---|
| Aniracetam • Brivaracetam • Coluracetam • Etiracetam/Levetiracetam • Fasoracetam • Nebracetam • Nefiracetam • Oxiracetam • Phenylpiracetam • Piracetam • Pramiracetam • Rolipram • Rolziracetam • Seletracetam |
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies